Daniela Monti

Title: Daniela Monti: Innovator in Ophthalmic Compositions

Introduction

Daniela Monti is a prominent inventor based in Pisa, Italy. She has made significant contributions to the field of ophthalmology through her innovative research and development of ophthalmic compositions. Her work focuses on enhancing the treatment of corneal lesions and improving the comfort of contact lens users.

Latest Patents

Monti holds a patent for "Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization." This invention includes ophthalmic solutions containing arabinogalactans, which provide protective activity on the corneal epithelium. The compositions are particularly suitable for use as artificial tears, stimulating the recovery of corneal lesions. They contain between 1% to 10% by weight of arabinogalactan in an aqueous solution, along with other excipients such as tonicity-adjusting agents, pH correctors, buffers, and preservatives, excluding benzalkonium chloride. Notably, these compositions have a virtually negligible viscosity while being sufficiently mucoadhesive to ensure a considerable permanence time in the application area. They are well-tolerated and exhibit significant re-epithelization capacity.

Career Highlights

Monti is currently associated with Opocrin S.p.a., where she continues to advance her research in ophthalmic solutions. Her dedication to innovation in this field has positioned her as a key figure in the development of effective treatments for eye care.

Collaborations

Throughout her career, Monti has collaborated with esteemed colleagues such as Patrizia Chetoni and Susi Burgalassi. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Daniela Monti's contributions to ophthalmic compositions demonstrate her commitment to improving eye care solutions. Her innovative patent reflects her expertise and dedication to advancing the field of ophthalmology.